The <scp>NRF2</scp> antagonist <scp>ML385</scp> inhibits <scp>PI3K‐mTOR</scp> signaling and growth of lung squamous cell carcinoma cells
Lili Ji(Nantong University), Ming‐Sound Tsao(Kumamoto University)
Cited by 45
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
|New England Journal of Medicine|2013|1.4k